Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,438 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Recruiting

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

NCT05287945

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +22 more
Locations
  • Stanford Palo Alto, California, United States
  • Washington University in St. Louis St Louis, Missouri, United States
  • University of Texas - MD Anderson Cancer Center Houston, Texas, United States
  • START Lisbon - Hospital de Santa Maria Av Lisbon, Portugal
View Trial Details
Recruiting

Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)

NCT05431270

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Carolina BioOncology Institute Huntersville, North Carolina, United States
  • Sarah Cannon Research Institute University of Oklahoma Oklahoma City, Oklahoma, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

NCT06757634

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • UCLA Hematology Oncology Santa Monica Los Angeles, California, United States
  • BRCR Medical Center, Inc- Internal Medicine Plantation, Florida, United States
View all 203 locations
View Trial Details
Recruiting

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

NCT07094204

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +24 more
Locations
  • UCLA Santa Monica Hematology Oncology Santa Monica, California, United States
  • Winship Cancer Institute at Emory University Atlanta, Georgia, United States
  • Ochsner Health Jefferson, Louisiana, United States
  • START Midwest Grand Rapids, Michigan, United States
View all 20 locations
View Trial Details
Recruiting

Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer

NCT06824064

Conditions
Advanced Colorectal Cancer, Colonic Diseases, Colorectal Neoplasms, +14 more
Locations
  • Christiana Care Newark, Delaware, United States
  • Community Clinical Trials Kingwood, Texas, United States
  • Pan Oncology San Juan, Puerto Rico
  • Tam Anh TP. Ho Chi Minh General Hospital Ho Chi Minh City, Vietnam
View Trial Details
Recruiting

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

NCT05379985

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +45 more
Locations
  • UC Irvine/Chao Family Comprehensive Cancer Center Orange, California, United States
  • UCLA Santa Monica, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Piedmont Healthcare Atlanta, Georgia, United States
View all 21 locations
View Trial Details
Recruiting

Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)

NCT07432295

Conditions
Adenocarcinoma Of Esophagus, Advanced Cancer, Digestive System Diseases, +16 more
Locations
  • I-Mab Site 1016 Goodyear, Arizona, United States
  • I-MAB Site 1005 Duarte, California, United States
  • I-Mab Site 1002 Boston, Massachusetts, United States
  • I-Mab Site 2001 Beijing, China
View Trial Details

Related conditions